Preferred Label : Emtricitabine, Rilpivirine, Tenofovir Drug Combination;
MeSH definition : A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir
disoproxil fumarate. It is used to treat HIV INFECTIONS.;
MeSH synonym : Emtricitabine Rilpivirine Tenofovir Drug Combination; Emtricitabine-Rilpivirine-Tenofovir Drug Combination; Combination, Emtricitabine-Rilpivirine-Tenofovir Drug; Drug Combination, Emtricitabine-Rilpivirine-Tenofovir;
MeSH hyponym : complera;
Wikipedia link : https://en.wikipedia.org/wiki/Complera;
Is substance : O;
Origin ID : D000068678;
UMLS CUI : C4042827;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir
disoproxil fumarate. It is used to treat HIV INFECTIONS.
http://www.has-sante.fr/portail/jcms/c_2570617/fr/eviplera
http://www.has-sante.fr/portail/jcms/c_1250131/eviplera
2015
false
France
French
evaluation of the transparency committee
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
administration, oral
insurance, health, reimbursement
emtricitabine, tenofovir disoproxil and rilpivirine
adult
HIV-1
hiv infections
anti-hiv agents
anti-hiv agents
clinical trials, phase iii as topic
treatment outcome
---
http://www.has-sante.fr/portail/jcms/c_1334848/eviplera-rilpivirine/emtricitabine/tenofovir-association-fixe-de-trois-antiretroviraux
http://www.has-sante.fr/portail/jcms/c_1334837/eviplera-09052012-synthese-ct11958
http://www.has-sante.fr/portail/jcms/c_1250738/eviplera-09052012-avis-ct11958
2012
false
France
French
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
administration, oral
anti-hiv agents
emtricitabine, tenofovir disoproxil and rilpivirine
anti-hiv agents
hiv infections
HIV-1
insurance, health, reimbursement
treatment outcome
adult
clinical trials, phase iii as topic
guidelines for drug use
evaluation of the transparency committee
randomized controlled trials as topic
drug resistance, viral
---
http://www.meddispar.fr/Medicaments/EVIPLERA-200-FL-30/(type)/letter/(value)/E/(cip)/3400921947359
2012
false
France
French
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
drug information
administration, oral
drug prescriptions
legislation, drug
emtricitabine, tenofovir disoproxil and rilpivirine
anti-hiv agents
---
https://www.ema.europa.eu/medicines/human/EPAR/Eviplera
2012
false
United Kingdom
French
English
package leaflet
drug evaluation
summary of product characteristics
syndication feed
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
HIV reverse transcriptase
treatment outcome
drug approval
administration, oral
hiv infections
HIV-1
reverse transcriptase inhibitors
reverse transcriptase inhibitors
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and rilpivirine
---